from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2418c/-

LFCtreatmentdescriptionclass of inhibitor

-1.961

Amikacinug/mL Amikacintranslation

-1.291

Cap5-10ug/mL Capreomycintranslation

-1.786

Rox10-50 ug/mL Roxithromycintranslation

-0.451

SM2-5 ug/mL Streptomycintranslation

-3.186

Tet5-10 ug/mL Tetracyclinetranslation

-1.380

Rif0.2-5ug/mL Rifampicintranscription

-0.032

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.743

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.253

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.410

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.461

Clofazimine10-13 ug/mL Clofaziminerespiration

0.803

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.306

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.786

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.039

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.619

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.306

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.366

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.002

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.386

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.089

KCN5-20 ug/mL Potassium cyaniderespiration

1.070

NaN30.2-2 mM Sodium aziderespiration

0.081

Nigericin50 uM Nigericinrespiration

-1.091

TRC10-150 ug/mL Triclosanrespiration

-0.188

TRZ10-25 ug/mL Thioridazinerespiration

-1.098

Valinomycin0.5-10 uM Valinomycinrespiration

1.280

ZnSO42 mM ZnSO4respiration

-0.163

menadione6-10 ug/mL Menadionerespiration

-0.475

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.418

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.555

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.234

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.308

NRP_1Non-replicating persistence stage 1dosRassociated

0.733

Amp0.2mg/mL AmpicillincellWall

0.507

Cephalexin20-100 ug/mL CephalexincellWall

0.419

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.149

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.095

EMB10-20 ug/mL EthambutolcellWall

0.839

Eta12-40 ug/mL EthionamidecellWall

1.192

INH0.2-0.4 ug/mL IsoniazidcellWall

0.413

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.227

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.125

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.019

BZA0.12 mg/mL BenzamidearomaticAmides

0.006

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.136

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.767

H2O24 mM hydrogen peroxideDNAdamaging

-0.124

Levo10 ug/mL LevofloxacinDNAdamaging

0.014

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.637

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.307

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.029

UVUV-irradiationDNAdamaging

-2.210

ARP41-4 ug/mL Antitubercular compound ARP4?

0.301

Antimycin12.5-50 ug/mL Antimycin A?

0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.610

PA_110-50 ug/mL Antitubercular compound PA-1?

0.502

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.520

PA8240.2-2 ug/mL PA-824?

0.099

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.519

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.433

Verapamil50 uM Verapamil?

1.116

mercaptoethanol2 mM 2-Mercaptoethanol?

0.373

methoxatin10-20 ug/mL Methoxatin?